Search Result |
Top |
Entry | Name | Name(TN) | Disease |
---|---|---|---|
D05014 |
Metreleptin (USAN/INN) Mettreleptin (genetical recombination) (JAN) |
Metreleptin (TN) Myalept (TN) |
Lipodystrophy [DS:H01475] |
D06348 | Yttrium Y 90 epratuzumab (USAN) | LymphoCide (TN) | |
D06349 | Yttrium Y 90 epratuzumab tetraxetan (USAN) | ||
D06350 | Yttrium Y 90 labetuzumab (USAN) | CES-Cide (TN) | |
D06351 | Yttrium Y 90 labetuzumab tetraxetan (USAN) | ||
D06352 | Yttrium Y 90 tacatuzumab (USAN) | AFP-Cide (TN) | |
D06668 | Yttrium Y 90 tacatuzumab tetraxetan (USAN) | AFP-Cide (TN) | |
D09700 | Yttrium Y 90 clivatuzumab tetraxetan (USAN) | ||
D10214 | Adsorbed diphtheria-purified pertussis-tetanus-inactivated polio combined vaccine |
Quattrovac (TN) Tetrabik (TN) |
|
D10794 | Patisiran sodium (JAN) | Onpattro (TN) | Hereditary transthyretin-mediated amyloidosis [DS:H00845] |
D11916 | Vutrisiran sodium (JAN) | Amvuttra (TN) | Polyneuropathy of hereditary transthyretin-mediated amyloidosis [DS:H00845] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |